tay-sachs disease

C2
UK/ˌteɪ ˈsæks dɪˌziːz/US/ˌteɪ ˈsæks dɪˌziz/

Technical/Medical

My Flashcards

Definition

Meaning

A rare, inherited, and fatal neurodegenerative disorder caused by a deficiency of the enzyme hexosaminidase A, leading to the accumulation of harmful substances in nerve cells, primarily affecting infants.

In medical and genetic contexts, the term refers specifically to the GM2 gangliosidosis resulting from mutations in the HEXA gene. It is often used as a paradigm for autosomal recessive genetic disorders, genetic screening, and discussions of carrier frequency in specific populations (e.g., Ashkenazi Jewish, French Canadian).

Linguistics

Semantic Notes

The term is a proper noun (eponym) derived from the surnames of the physicians who described it. It is almost exclusively used in medical, genetic, and public health contexts. It is not used metaphorically.

Dialectal Variation

British vs American Usage

Differences

No significant lexical differences. Both varieties use the full term 'Tay-Sachs disease'. The abbreviated form 'Tay-Sachs' is equally common in both.

Connotations

Identical strong connotations of severe infant illness, genetic tragedy, and population-specific genetic screening.

Frequency

Equally low-frequency in general discourse but standard in relevant medical/genetic contexts in both regions.

Vocabulary

Collocations

strong
infantile Tay-Sachs diseasejuvenile Tay-Sachscarrier of Tay-Sachsdiagnosed with Tay-SachsTay-Sachs screeningTay-Sachs gene
medium
familial Tay-Sachshistory of Tay-Sachstesting for Tay-Sachsmutation for Tay-Sachsfatal Tay-Sachs
weak
rare Tay-Sachsdevastating Tay-Sachsclassic Tay-Sachs

Grammar

Valency Patterns

[Patient] *has/ is diagnosed with/ suffers from* Tay-Sachs disease.[Screening] *tests for/ identifies carriers of* Tay-Sachs.[Gene] *causes/ is responsible for/ leads to* Tay-Sachs.

Vocabulary

Synonyms

Neutral

GM2 gangliosidosis, type 1Hexosaminidase A deficiency

Usage

Context Usage

Academic

Used in genetics, neurology, paediatric, and biochemistry literature. E.g., 'The study examined HEXA gene mutations in a Tay-Sachs cohort.'

Everyday

Rarely used outside of discussions of personal/family medical history, genetic counselling, or community health initiatives.

Technical

Precise term in clinical diagnoses, genetic test results, and medical research papers.

Examples

By Part of Speech

adjective

British English

  • The Tay-Sachs screening programme is well-established in the community.
  • They sought Tay-Sachs-specific genetic counselling.

American English

  • The Tay-Sachs test came back positive for the carrier state.
  • Research focused on Tay-Sachs-related neuronal degradation.

Examples

By CEFR Level

B1
  • Tay-Sachs disease is a very serious illness that babies can be born with.
B2
  • Couples with a family history of genetic disorders may choose to be tested for Tay-Sachs disease.
C1
  • The pathognomonic cherry-red spot on the macula is a key diagnostic feature of infantile Tay-Sachs disease.

Learning

Memory Aids

Mnemonic

Think of the 'Sachs' as 'sacks' that are faulty and can't process waste in brain cells, leading to a 'tragic' (Tay) outcome.

Conceptual Metaphor

DISEASE IS A THIEF (of motor skills, vision, and ultimately life).

Watch out

Common Pitfalls

Translation Traps (for Russian speakers)

  • Do not translate component parts ('Tay', 'Sachs'). It is a borrowed eponym: 'болезнь Тея-Сакса'. Avoid calques like 'болезнь мешочков'.

Common Mistakes

  • Pronouncing 'Sachs' as /sætʃs/ (like 'satchels') instead of /sæks/.
  • Using it as a countable noun (e.g., 'a Tay-Sachs') instead of an uncountable proper name for a condition.
  • Confusing it with other lysosomal storage diseases (e.g., Niemann-Pick, Gaucher's).

Practice

Quiz

Fill in the gap
Prospective parents of Ashkenazi Jewish heritage are often advised to undergo carrier screening for .
Multiple Choice

What is the primary biochemical defect in Tay-Sachs disease?

FAQ

Frequently Asked Questions

No, it is an inherited genetic disorder, not an infectious disease.

Currently, there is no cure. Treatment is supportive and focuses on managing symptoms and providing comfort care.

Individuals of Ashkenazi Jewish, French Canadian, Pennsylvania Dutch, or Cajun descent have a higher carrier frequency, though it can occur in any population.

Typically, an apparent normal development followed by a loss of motor skills, exaggerated startle response, and progressive muscle weakness around 3-6 months of age.